Massimo Bani

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Antoine Regnault, Babak Boroojerdi, Juliette Meunier et al. · Journal of Neurology · 2019 · 224 citations · Full text

A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety

Tomas Furmark, Lieuwe Appel, Susanne Henningsson et al. · Journal of Neuroscience · 2008 · 209 citations · Full text

Neuropsychology, Amygdala Activity, Placebo Response +21

Cerebral Blood Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist GR205171, Citalopram, or Placebo

Tomas Furmark, Lieuwe Appel, Åsa Michelgård et al. · Biological Psychiatry · 2005 · 205 citations

Psychiatry, Behavioral Neuroscience, Medicine +11

Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist

Graham E. Searle, John D. Beaver, Robert A. Comley et al. · Biological Psychiatry · 2010 · 149 citations

Positron Emission Tomography, Health Sciences, Psychiatry +10

New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.

Francesco Makovec, Renan Campos Chisté, Massimo Bani et al. · PubMed · 1985 · 116 citations

Gastrointestinal Pharmacology, Gastroenterology, Pharmacotherapy +16